Half-year report · HY
4043.TEDINET S100WZ85
Period2025-04-01 → 2025-09-30
Filed2025-11-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥163.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥343.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥165.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥19.2bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥14.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥18.9bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥29.6bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.6bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥17.8bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥16.8bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.1bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥23.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.6bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥12.1bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥11.4bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥536.7bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥476.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥462.8bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥251.0bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥202.3bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥285.7bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥273.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥266.4bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥128.2bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥75.5bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥127.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥74.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.8bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥47.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥22.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥52.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥26.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥18.3bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥23.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥11.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥47.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥168.81 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥325.08 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥161.81 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 50.6% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.9% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥20.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥15.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥4.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥5.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥5.7bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥3.9bn |
| Cementreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥32.4bn |
| Cementreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥32.1bn |
| Cementreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥309m |
| Cementreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥4.8bn |
| Chemicalsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥52.3bn |
| Chemicalsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥52.3bn |
| Chemicalsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥55m |
| Chemicalsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥5.6bn |
| Eco Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.7bn |
| Eco Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.6bn |
| Eco Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥59m |
| Eco Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥256m |
| Electronic And Advanced Materialsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥42.6bn |
| Electronic And Advanced Materialsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥42.1bn |
| Electronic And Advanced Materialsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥482m |
| Electronic And Advanced Materialsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥7.0bn |
| Life Sciencereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥19.3bn |
| Life Sciencereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥19.3bn |
| Life Sciencereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥7m |
| Life Sciencereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥169.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥163.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥23.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥19.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥14.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥4.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥5.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥5.0bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥3.4bn |
| Cementreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥32.3bn |
| Cementreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥32.2bn |
| Cementreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥76m |
| Cementreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥3.7bn |
| Chemicalsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥57.3bn |
| Chemicalsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥57.2bn |
| Chemicalsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥71m |
| Chemicalsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥5.3bn |
| Eco Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Eco Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| Eco Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥99m |
| Eco Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥220m |
| Electronic And Advanced Materialsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥39.8bn |
| Electronic And Advanced Materialsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥39.3bn |
| Electronic And Advanced Materialsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥430m |
| Electronic And Advanced Materialsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.9bn |
| Life Sciencereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥20.0bn |
| Life Sciencereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥20.0bn |
| Life Sciencereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥14m |
| Life Sciencereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥3.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥170.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥165.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥5.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥17.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 698
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income attributable to non controlling interests | Prior1InterimDuration | -502000000 | JPY |
| Comprehensive income attributable to non controlling interests | InterimDuration | 474000000 | JPY |
| Income before income taxes | Prior1InterimDuration | 16802000000 | JPY |
| Income before income taxes | InterimDuration | 17814000000 | JPY |
| Depreciation and amortization ope cf | Prior1InterimDuration | 9597000000 | JPY |
| Depreciation and amortization ope cf | InterimDuration | 9860000000 | JPY |
| Increase decrease in provision ope cf | Prior1InterimDuration | 271000000 | JPY |
| Increase decrease in provision ope cf | InterimDuration | -706000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1InterimDuration | -5000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | InterimDuration | 40000000 | JPY |
| Increase decrease in net defined benefit asset ope cf | Prior1InterimDuration | -12000000 | JPY |
| Increase decrease in net defined benefit asset ope cf | InterimDuration | -737000000 | JPY |
| Interest and dividends income ope cf | Prior1InterimDuration | -475000000 | JPY |
| Interest and dividends income ope cf | InterimDuration | -629000000 | JPY |
| Foreign exchange losses gains ope cf | Prior1InterimDuration | 201000000 | JPY |
| Foreign exchange losses gains ope cf | InterimDuration | -43000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | Prior1InterimDuration | -33000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | InterimDuration | -10000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1InterimDuration | -1141000000 | JPY |
| Loss gain on sales of investment securities ope cf | InterimDuration | -490000000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | Prior1InterimDuration | － | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | InterimDuration | 2000000 | JPY |
| Gain on share exchange of affiliated companies ope cf | Prior1InterimDuration | -2313000000 | JPY |
| Gain on share exchange of affiliated companies ope cf | InterimDuration | － | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1InterimDuration | -508000000 | JPY |
| Equity in earnings losses of affiliates ope cf | InterimDuration | -638000000 | JPY |
| Subsidy income ope cf | Prior1InterimDuration | -82000000 | JPY |
| Subsidy income ope cf | InterimDuration | -38000000 | JPY |
| Interest expenses ope cf | Prior1InterimDuration | 437000000 | JPY |
| Interest expenses ope cf | InterimDuration | 578000000 | JPY |
| Loss on reduction of noncurrent assets ope cf | Prior1InterimDuration | 80000000 | JPY |
| Loss on reduction of noncurrent assets ope cf | InterimDuration | 45000000 | JPY |
| Impairment loss ope cf | Prior1InterimDuration | 96000000 | JPY |
| Impairment loss ope cf | InterimDuration | 1431000000 | JPY |
| Loss gain on disposal of noncurrent assets ope cf | Prior1InterimDuration | 165000000 | JPY |
| Loss gain on disposal of noncurrent assets ope cf | InterimDuration | 156000000 | JPY |
| Gain on insurance claim ope cf | Prior1InterimDuration | -43000000 | JPY |
| Gain on insurance claim ope cf | InterimDuration | － | JPY |
| Compensation for damage income ope cf | Prior1InterimDuration | － | JPY |
| Compensation for damage income ope cf | InterimDuration | -157000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1InterimDuration | 11619000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | InterimDuration | 6542000000 | JPY |
| Decrease increase in inventories ope cf | Prior1InterimDuration | -1718000000 | JPY |
| Decrease increase in inventories ope cf | InterimDuration | -1086000000 | JPY |
| Decrease increase in other current assets ope cf | Prior1InterimDuration | 1303000000 | JPY |
| Decrease increase in other current assets ope cf | InterimDuration | -543000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1InterimDuration | -3194000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | InterimDuration | -3722000000 | JPY |
| Increase decrease in other current liabilities ope cf | Prior1InterimDuration | -2436000000 | JPY |
| Increase decrease in other current liabilities ope cf | InterimDuration | -2902000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |